Company intelligence / Profile preview

PregnanTech

Misgav, Northern District, Israel

Ownership: Private
Development stage: Other

Overview

PregnanTech's LIONESS™, a disposable silicone vaginal device designed to prevent preterm birth by mechanically supporting the cervix, has undergone successful preclinical trials and a Phase 1 clinical safety and feasibility study in pregnant women at high risk for preterm birth, with results showing a high rate of term births and no significant device-related side effects[5][4]. A pivotal study in the US is planned for 2025.

Therapeutic areas: Women's Health
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

King's College Hospital (clinical collaboration with Prof. Kypros Nicolaides)[4]Sheba Medical Center (Israel)

Beyond the preview

Go deeper on PregnanTech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PregnanTech.

Explore the full profile